-
Mashup Score: 1
The proposed method is generalizable in the common occurrence in which EGFR-status data are missing.
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 0A Practical Guide to Understanding Cost-Effectiveness Analyses - 2 year(s) ago
Cost-effectiveness analysis is a way to understand the value of a health care intervention in terms of assessing the money spent to produce beneficial outcomes. Cost-effectiveness analyses are used by various stakeholders for such purposes because health care resources and financing may be scarce, depending on the economy, and certain interventions may be costly to produce such outcomes compared…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0
Asthma is one of the most common and costly chronic conditions. Cost-effectiveness analyses focus on weighing different interventions against better or worse outcomes and are useful in deciding what is worth the incremental cost and what is not. Such analyses are employed to mitigate the rising cost of asthma and inform clinical management, including asthma management guidelines such as the…
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 0
Clinical and methodological considerations when interpreting meta-analyses of beta-blocker use in patients with chronic obstructive pulmonary disease
Source: PubMedCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 7
Longitudinal analyses of antibody responses to SARS-CoV-2 demonstrate that individuals with sustained virus-specific IgG production have shorter disease trajectories, with a subset demonstrating increased somatic hypermutation and higher levels of activated CD4+ cells.
Source: CellCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 3
Breast cancer is a highly heterogeneous disease with variable outcomes and subtype-driven treatment approaches, making precision medicine a considerable challenge. Proteogenomic analyses of 122 primary breast cancers provide insights into clinically relevant biology, including cell cycle dysregulation, tumor immunogenicity, aberrant metabolism, and heterogeneity in therapeutic target expression.
Source: CellCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 7
Longitudinal analyses of antibody responses to SARS-CoV-2 demonstrate that individuals with sustained virus-specific IgG production have shorter disease trajectories, with a subset demonstrating increased somatic hypermutation and higher levels of activated CD4+ cells.
Source: CellCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0Longitudinal outcomes of severe asthma: real-world evidence of multidimensional analyses - 4 year(s) ago
There have been few studies assessing long-term outcomes of asthma based on regular follow-up data.
Categories: Allergy-Immunology, Latest HeadlinesTweet
-
Mashup Score: 29
Analyses of CD4+ T cells from 40 COVID-19 patients show that severe disease is associated with increased cytotoxic follicular helper (TFH) cells and cytotoxic T helper cells and a reduction in regulatory T cells.
Source: CellCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Now Online! #Analyses from 40 #COVID19 #patients show that severe #disease is associated with #cytotoxic follicular helper cells and T-helper cells. 👉 https://t.co/3u62BQzvPh For all @CellPressNews #coronavirus research and commentary, visit https://t.co/BCdU2ltXnp #SARSCoV2 https://t.co/h1s5c1nSu8
-
-
Mashup Score: 0Trajectory Analyses of Adherence Patterns in a Real-Life Moderate to Severe Asthma Population - 4 year(s) ago
Global Initiative for Asthma step 5 therapies (GINA-5), other than inhaled corticosteroids and long-acting β-agonists in fixed dose combinations (ICS/LABA FDC), often entail more expensive (eg, monoclonal biologics) or less safe (eg, maintenance oral corticosteroids [OCS]) treatments. It is therefore important to assess poor inhaler adherence as a possible cause of suboptimal response to ICS/LABA…
Categories: Allergy-Immunology, Latest HeadlinesTweet
Accounting for #EGFR #mutations in #epidemiological #analyses of #non- #small #cell #lung #cancers: Examples based on the #International #Lung #Cancer #Consortium data https://t.co/EJObS3jRDh https://t.co/2gubG2K4k6